Global /China /Healthcare /Drug Manufacturers - General /1643

Modern Chinese Medicine Group Co., Ltd.

1643

• SHEK: 1643 • Delayed

2.82HKD -4.1%

0.3599 USD

As of 16 June 2026, Modern Chinese Medicine Group Co., Ltd. has a market cap of $126.82M USD, ranking #23817 globally and #5853 in China. It ranks #2140 in the Healthcare sector, and #776 in the Drug Manufacturers - General industry.

Global Rank

23817

Country Rank

5853

Sector Rank

2140

Industry Rank

776

Key Stats

Market Cap

$126.82MUSD

993.6M HKD

Enterprise Value

$237.52MUSD

1.86B HKD

Revenue (TTM)

$20.62MUSD

161.55M HKD

EBITDA (TTM)

-$1.06MUSD

-8.34M HKD

Net Income (TTM)

-$1.93MUSD

-15.09M HKD

EBITDA Margin

-5.2%

Profit Margin

-9.3%

PS Ratio

13.1

PB Ratio

3.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hongli Zhang open_in_new

Employees

189

Founded

1986

Website

cdysjdyy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.1%	5%	26%	287%	326%	476%	728%	513%	230%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	1643 现代中药集团有限公司 Ordinary Shares ISIN: KYG6181B1068 Shares Out.: Shares Outstanding: 720.0M¹ Shares Float: 180.0M² TV: TradingView: HKEX: 1643 SA: Stock Analysis: HKG: 1643 YF: Yahoo Finance: 1643.HK GF: Google Finance: HKG: 1643 BA: Barron's: 1643 MS: Morningstar: XHKG: 01643	2.82 HKD	TV: TradingView: HKEX: 1643 SA: Stock Analysis: HKG: 1643 YF: Yahoo Finance: 1643.HK GF: Google Finance: HKG: 1643 BA: Barron's: 1643 MS: Morningstar: XHKG: 01643

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, heart wellness capsules, menstrual discomfort relief, liver detox tablets, liver-dispersing and stomach regulating pills, fever- removing and detoxification pills, kidney invigoration pills, and huoxiang zheng qi pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and for symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 42K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 39K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 22K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 15K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 13K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 13K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 601K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 431K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 284K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 253K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 227K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 216K%	15.1	United States

chevron_leftBack